Literature DB >> 12325078

Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype.

Friedrich Asmus1, Alexander Zimprich, Sophie Tezenas Du Montcel, Christian Kabus, Günther Deuschl, Andreas Kupsch, Ulf Ziemann, Mirna Castro, Andrea A Kühn, Tim M Strom, Marie Vidailhet, Kailash P Bhatia, Alexandra Dürr, Nicholas W Wood, Alexis Brice, Thomas Gasser.   

Abstract

Mutations in the gene for epsilon-sarcoglycan (SGCE) have been found to cause myoclonus-dystonia syndrome. We now report clinical and genetic findings in nine additional European families with myoclonus-dystonia syndrome. The clinical presentation in 24 affecteds was homogeneous with myoclonus predominantly of neck and upper limbs in 23 of them and dystonia, presenting as cervical dystonia and/or writer's cramp, in 13 cases. Six novel and one previously known heterozygous SGCE mutations were identified. SGCE deficiency seems to be the common pathogenetic mechanism in myoclonus-dystonia syndrome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12325078     DOI: 10.1002/ana.10325

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  27 in total

1.  Epsilon-sarcoglycan is not involved in sporadic Gilles de la Tourette syndrome.

Authors:  Friedrich Asmus; Sarah Schoenian; Peter Lichtner; Marita Munz; Petra Mayer; Bertram Muller-Myhsok; Alexander Zimprich; Helmut Remschmidt; Johannes Hebebrand; Oliver Bandmann; Thomas Gasser
Journal:  Neurogenetics       Date:  2005-02       Impact factor: 2.660

Review 2.  Engineering animal models of dystonia.

Authors:  Janneth Oleas; Fumiaki Yokoi; Mark P DeAndrade; Antonio Pisani; Yuqing Li
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

Review 3.  Substance of abuse and movement disorders: complex interactions and comorbidities.

Authors:  Andres Deik; Rachel Saunders-Pullman; Marta San Luciano
Journal:  Curr Drug Abuse Rev       Date:  2012-09

4.  Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes.

Authors:  S Tezenas du Montcel; F Clot; M Vidailhet; E Roze; P Damier; C P Jedynak; A Camuzat; A Lagueny; L Vercueil; D Doummar; L Guyant-Maréchal; J-L Houeto; G Ponsot; S Thobois; M-A Cournelle; A Durr; F Durif; B Echenne; D Hannequin; C Tranchant; A Brice
Journal:  J Med Genet       Date:  2005-10-14       Impact factor: 6.318

5.  Myoclonus-dystonia and epilepsy in a family with a novel epsilon-sarcoglycan mutation.

Authors:  Kristoffer Haugarvoll; Charalampos Tzoulis; Gia T Tran; Bjørn Karlsen; Bernt A Engelsen; Per M Knappskog; Laurence A Bindoff
Journal:  J Neurol       Date:  2013-12-03       Impact factor: 4.849

6.  Locus Pocus.

Authors:  H A Jinnah
Journal:  Mov Disord       Date:  2016-08-22       Impact factor: 10.338

7.  Candidate-gene testing for orphan limb-girdle muscular dystrophies.

Authors:  S Aurino; G Piluso; V Saccone; M Cacciottolo; F D'Amico; M Dionisi; A Totaro; A Belsito; U Di Vicino; V Nigro
Journal:  Acta Myol       Date:  2008-12

8.  Reduced striatal D2 receptor binding in myoclonus-dystonia.

Authors:  R J Beukers; J Booij; N Weisscher; F Zijlstra; T A M J van Amelsvoort; M A J Tijssen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-22       Impact factor: 9.236

9.  Prominent Lower-Limb Involvement in a Family with Myoclonus-Dystonia.

Authors:  Christopher Kobylecki; Dinesh Damodaran; Bronwyn Kerr; Richard W Newton; Monty A Silverdale
Journal:  Mov Disord Clin Pract       Date:  2014-05-26

Review 10.  Update on pediatric dystonias: etiology, epidemiology, and management.

Authors:  Emilio Fernández-Alvarez; Nardo Nardocci
Journal:  Degener Neurol Neuromuscul Dis       Date:  2012-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.